Remove Development Remove Health Care Remove Leadership Remove Venture Capitalist
article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

With its Emerging Businesses (EB) group (where one of us serves as President), Merck started a journey about three years ago with a core investment thesis: there are areas of growing unmet need in health care that intersect with its established competencies.

article thumbnail

Big Companies Can Unleash Innovation, Rather than Shackle It

Harvard Business Review

Here's why: the innovation revolution spurred by venture capitalists decades ago has created the conditions in which scale allows big companies to shift from shackling innovation to unleashing it. The effort also positions Medtronic to dramatically expand in those markets as it develops new technologies that lower costs. (

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The 5 Things IBM Needs to Do to Win at AI

Harvard Business Review

The kinds of shifts we’re talking about have come more naturally to greatly successful startups of the last two decades — Google, Amazon, Uber, and Facebook among them — and their venture capital investors. Develop a portfolio of capabilities with different risk/return profiles. Acquire ideas, not just revenue.

article thumbnail

The $300 House: The Marketing Challenge

Harvard Business Review

That's enough to participate in other productivity or life-enhancing investments, like a well, or a roof, or health care. So Acumen finds entrepreneurs on site in the developing world, funds them, teaches them and pushes them to build really big organizations. That's a surplus of $700 a year. It puts the edge much further away.